Docoh
Loading...

BLRX Bioline Rx

BioLineRx Ltd. is a clinical stage biopharmaceutical company focused on oncology. The company was founded in April 2003 and is headquartered in Modi'in, Israel.

BLRX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

23 Feb 21
28 Oct 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Bioline Rx earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 33 30 +10.0%
Opened positions 9 28 -67.9%
Closed positions 6 3 +100.0%
Increased positions 2 0 NEW
Reduced positions 8 0 NEW
13F shares
Current Prev Q Change
Total value 28.39M 41.17M -31.0%
Total shares 12.37M 15.77M -21.5%
Total puts 32.4K 0 NEW
Total calls 29.5K 0 NEW
Total put/call ratio 1.1
Largest owners
Shares Value Change
Biotechnology Value Fund L P 5.95M $11.78M 0.0%
Novartis Pharma 5M $12.6M 0.0%
Parkman Healthcare Partners 734.03K $2.06M +70.7%
MS Morgan Stanley 226.82K $637K -43.1%
Renaissance Technologies 77.81K $219K -84.6%
LPLA LPL Financial 66.08K $186K 0.0%
Citadel Advisors 45.1K $127K NEW
Intellectus Partners 40.5K $114K 0.0%
Game Plan Financial Advisors 29K $81K +11.5%
ACT Capital Management, LLLP 27.5K $78K NEW
Largest transactions
Shares Bought/sold Change
Sio Capital Management 0 -2.74M EXIT
Renaissance Technologies 77.81K -427.31K -84.6%
Parkman Healthcare Partners 734.03K +303.92K +70.7%
Silverarc Capital Management 0 -200K EXIT
MS Morgan Stanley 226.82K -171.59K -43.1%
Psagot Investment House 0 -117K EXIT
Schonfeld Strategic Advisors 0 -76.5K EXIT
Susquehanna Fundamental Investments 19.03K -55.6K -74.5%
Citadel Advisors 45.1K +45.1K NEW
ACT Capital Management, LLLP 27.5K +27.5K NEW
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Adv, affirmatively, al, API, Art, ATMP, BNY, bore, Caesarstone, CAT, cemiplimab, chain, characterized, clock, communicable, concurrent, contrary, covenant, CRL, CSTE, CTR, DCF, deepening, DMC, downsizing, effort, elevate, elevated, evolving, extracellular, frame, GDP, GDPR, GVP, Halozyme, HCW, HiberCell, inflamed, invite, LIBTAYO, LLB, LLM, Macarulla, mediator, MM, myeloablation, node, notably, online, organisational, para, pegilodecakin, permissible, precautionary, precursor, privacy, properly, provisional, pseudonymized, pulmonary, recession, rent, repaid, rescue, resource, respiratory, risky, salary, sample, seq, shelter, shift, signatory, standalone, strict, stricter, succeed, Tali, temporarily, tradable, Transferor, transposed, transposing, tree, turnover, unblinded, underwater, Underwriter, Underwriting, unregistered, unsatisfactory, Wainwright, wave, Wolfson, Wuhan, xenogenic, Yaron
Removed: admission, agenda, alive, Almagor, atezolizumab, Avenue, ballot, binding, biopharma, Biothera, blocker, Brightman, California, codified, collateral, collateralized, commitment, construed, convene, convening, COSO, creditor, declare, deny, depriving, dismissal, divided, Dloomy, ductal, Dynavax, exclusion, executed, finder, fit, flat, Floor, Francisco, hybrid, implantable, interactive, Irrespective, KY, lab, Lampert, lawful, leased, Lichtenstein, Lincoln, Linur, LP, LPC, Lytix, Madison, Mashaal, MSI, Neon, NewLink, Oberon, objected, offeror, Park, pertain, pledged, possession, preemptive, prohibit, proper, proportion, realizing, reconvened, reflected, repayable, repealing, resolution, reversed, Richard, Roche, San, Sansome, satisfying, shared, Similarly, simple, SPV, Subscription, surviving, takeover, TECENTRIQ, tendered, Tohmatsu, Touche, undertook, veterinary, wholesale, Zohar

Proxies

No filings